OVID: Total Utang marang Modal Ovid Rx
The stability of Ovid Therapeutics Inc. (OVID) relies on the reliability of global supply chains, as external conflicts may hinder drug distribution, which is clearly evidenced by the price chart on GURU.Markets, where the indicator stands at 0.06. Ovid Therapeutics Inc. (OVID) develops innovative methods for combating seizures and epilepsy through strategic alliances with partners, while research quality control is ensured by delegating tasks to proven external laboratories.
%20-%20Utang%20marang%20Modal&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_OVID_-_Ovid-Therapeutics-Inc._-_Debt-to-Capital "Rasio Total Utang marang Ekuitas: Ovid Therapeutics (OVID) kanggo 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
Rincian metrik lan analitis perusahaan Ovid Therapeutics (OVID)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Ovid Therapeutics Inc.|OVID - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ovid Therapeutics Inc|OVID - Utang kumulatif perusahaan|Utang marang nilai buku Ovid Therapeutics|OVID - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ovid Therapeutics|Rasio cepet ovidrx.com
- statistik bathi lan rasio pasar:
Analisis fundamental perusahaan:Ovid Therapeutics Inc.
Ovid Therapeutics Inc. (OVID) is optimizing clinical trials for neurological drugs through the automation of biodata collection, which necessitates precise cost management. By analyzing the debt-to-equity history, an investor can see the ratio of total liabilities to equity, which determines the business's level of dependence on borrowed financing. A low ratio confirms financial autonomy and the asset's resilience to market shocks.
Pesaing wigati
Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Utang marang Ekuitas Harmony Biosciences|Utang marang Modal biohavenpharma.com BHVN|Rasio Total Utang marang Ekuitas AMLX (Amylyx Pharmaceuticals, Inc.)|Utang marang Ekuitas TRVI (Trevi Therapeutics Inc)|Total Utang marang Modal PRAX (Praxis Medicines)|Koefisien Total Utang marang Modal Anavex Life Sciences Corp (AVXL)|CeriBell, Inc. - Total Utang marang Modal|PRTA (Prothena Corporation PLC) - Rasio Utang marang Ekuitas|ALEC (alector.com) - Rasio Total Utang marang Ekuitas|Annexon Biosciences - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas OMER|NGNE (Neurogene Therapeutics) - Utang Agregat marang Modal|Total Utang marang Modal ACIU|VYGR (voyagertherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal NMRA (Neumora Therapeutics, Inc.)|Scilex Holding (SCLX) - Utang marang Modal|TVGN - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ACOG (Alpha Cognition)|CGTX: Total Utang marang Modal|inhibikase.com (IKT) - Total Utang marang Modal|Utang marang Ekuitas Cassava Sciences|Assertio Therapeutics - Utang Agregat marang Ekuitas|Total Utang marang Modal COYA|VTGN - Utang marang Modal|Acumen Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal cervomed.com CRVO|ATHE: Rasio Total Utang marang Ekuitas|Clene Inc. - Utang Agregat marang Modal|PEPG: Total Utang marang Modal|JUNS - Koefisien Total Utang marang Modal|RLMD (Relmada Therapeutics) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas annovisbio.com (ANVS)|Utang marang Ekuitas Grace Therapeutics, Inc. (GRCE)|Koefisien Total Utang marang Modal Firefly Neuroscience, Inc.|Klotho Neurosciences - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi NRSN|Reviva Pharmaceuticals - Total Utang marang Modal|Koefisien Total Utang marang Modal MetaVia Inc MTVA|NeurAxis (NRXS) - Utang marang Ekuitas|Rasio Utang marang Ekuitas HSDT|PASG (Passage Bio Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Neuphoria (NEUP)|Rasio Total Utang marang Ekuitas NERV (Minerva Neurosciences)|Koefisien Total Utang marang Modal athira.com|Utang marang Ekuitas Addex Therapeutics Ltd ADXN|Alzamend Neuro Inc. (ALZN) - Utang marang Modal|CYCN: Rasio Total Utang marang Ekuitas|PTIX: Utang marang Ekuitas|KTTA: Total Utang marang Modal|CRGT - Koefisien Total Utang marang Modal|ATXI (Avenue Therapeutics, Inc.) - Total Utang marang Modal|Rasio Utang marang Ekuitas BCLI (Brainstorm Cell Therapeutics Inc.)|Utang marang Ekuitas Cara Therapeutics, Inc (CARA)|Chromocell - Rasio Utang marang Ekuitas|Total Utang marang Modal ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Utang marang Modal|LBPH: Rasio Total Utang marang Ekuitas|MRNS - Total Utang marang Modal|NKGen (NKGN) - Utang marang Ekuitas|NeuroBo Pharma - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Sage Therapeutics, Inc.|Utang marang Modal synaptogen.com SNPX|Utang marang Ekuitas Trevena (TRVN)|VIGL - Utang marang Modal|Anew Medical - Rasio Total Utang marang Ekuitas|Cerevel Corp - Utang marang Ekuitas